Canton Strategic Holdings (CNTN) EPS (Basic) (2021 - 2026)
Canton Strategic Holdings' (CNTN) quarterly EPS (Basic) came in at -$0.23 in Q1 2026, up 76.93% YoY from -$0.13 in Q1 2025, and up 46.26% on a QoQ basis from -$0.42 in Q4 2025.
Powered by 
Analysis
Canton Strategic Holdings (CNTN) EPS (Basic) (2021 - 2026) Analysis & Trends
Canton Strategic Holdings (CNTN) has 6 years of EPS (Basic) data on file, last reported at -$0.23 in Q1 2026.
- Quarterly EPS (Basic) rose 76.93% year-over-year to -$0.23 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.31 (up 93.54% YoY) and the FY2025 annual result came in at -$1.34, up 85.76% from the prior year.
- EPS (Basic) climbed to -$0.23 in Q1 2026, from -$0.42 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.02 in Q4 2022 to a low of -$2.92 in Q4 2024.
- A 5-year average of -$0.8 and a median of -$0.28 in 2022 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2023 — EPS (Basic) sank 10761.86% — and 2025, when it surged 86.27%.
- Tracing CNTN's EPS (Basic) over 5 years: stood at -$0.02 in 2022, then slumped by 10761.86% to -$1.89 in 2023, then sank by 54.16% to -$2.92 in 2024, then soared by 85.48% to -$0.42 in 2025, then surged by 46.26% to -$0.23 in 2026.
- The last three EPS (Basic) figures came in at -$0.23 (Q1 2026), -$0.42 (Q4 2025), and -$0.34 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -3.06 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 0.18 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.06 |
| 10 | Canton Strategic Holdings | 493.37 Mn | 493.37 Mn | - | -0.09 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.09 |
| Mar 31, 2026 | -0.23 |
| Dec 31, 2025 | -0.42 |
| Sep 30, 2025 | -0.34 |
| Jun 30, 2025 | -0.64 |
| Mar 31, 2025 | -0.99 |
| Dec 31, 2024 | -2.95 |
| Sep 30, 2024 | -2.45 |
| Jun 30, 2024 | -2.42 |
| Mar 31, 2024 | -0.19 |
| Dec 31, 2023 | -1.89 |
| Sep 30, 2023 | -0.11 |
| Jun 30, 2023 | -0.16 |
| Mar 31, 2023 | -0.23 |
| Dec 31, 2022 | -0.16 |
| Sep 30, 2022 | -0.18 |
| Jun 30, 2022 | -0.14 |
| Mar 31, 2022 | -0.28 |
| Dec 31, 2021 | -0.06 |
| Sep 30, 2021 | -0.12 |